Freeline TherapeuticsHoldings Plc Analysis

Freeline Stock Analysis Notes

About 46.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. Freeline TherapeuticsHold recorded a loss per share of 11.4. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 12th of May 2023. Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Freeline Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. To learn more about Freeline TherapeuticsHoldings Plc call Michael JD at 44 14 3890 6870 or check out https://www.freeline.life.

Freeline TherapeuticsHold Investment Alerts

Freeline TherapeuticsHold Upcoming and Recent Events

Freeline Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Freeline TherapeuticsHold's market, we take the total number of its shares issued and multiply it by Freeline TherapeuticsHold's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Freeline TherapeuticsHold Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Freeline TherapeuticsHold prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Freeline shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Freeline TherapeuticsHold. By using and applying Freeline Stock analysis, traders can create a robust methodology for identifying Freeline entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

If you are still planning to invest in Freeline TherapeuticsHold check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline TherapeuticsHold's history and understand the potential risks before investing.